difference between a semaglutide and tirzepatide vs. Tirzepatide: Which GLP-1 Is Right for You? GLP-1 Medications for Weight Loss:

Notice the highlighted cells in the 5mg/mL and 10mg/mL columns

Retatrutide is only available through approved clinical trials

The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease

Petersen KF, Shulman GI

Many trial participants reported noticeable reductions in hunger and food intake during this phase, with weight loss varying by dose and titration

In a phase 2 clinical trial for obesity, 26 weeks of efinopegdutide (doses 5 to 10mg) resulted in up to 11.8% WL in people with obesity (without diabetes) compared to 7.5% WL with liraglutide 3 mg and 1.8% WL with placebo [77, 78]